This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. 10.1002/ijc.2921025220842FerlayJSoerjomataramIDikshitREserSMathersCRebeloMCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer2015136E3598610.1002/ijc.29210Open DOISearch in Google Scholar
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. ActaNeuropathol 2007; 114: 97-109. 10.1007/s00401-007-0243-417618441LouisDNOhgakiHWiestlerODCaveneeWKBurgerPCJouvetAThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol20071149710910.1007/s00401-007-0243-4Open DOISearch in Google Scholar
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131: 803-20. 10.1007/s00401-016-1545-127157931LouisDNPerryAReifenbergerGvon DeimlingAFigarella-BrangerDCaveneeWKThe 2016 World Health Organization classification of tumors of the central nervous system: a summaryActa Neuropathol20161318032010.1007/s00401-016-1545-1Open DOISearch in Google Scholar
Thumma SR, Fairbanks RK, Lamoreaux WT, Mackay AR, Demakas JJ, Cooke BS, et al. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis. World J Surg Oncol 2012; 10: 75. 10.1186/1477-7819-10-7522553975ThummaSRFairbanksRKLamoreauxWTMackayARDemakasJJCookeBSEffect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysisWorld J Surg Oncol2012107510.1186/1477-7819-10-75Open DOISearch in Google Scholar
Belkacemi Y, Bolle S, Bourdeaut F, Collin P, Cornu P, Delatre JY, et al. Guidelines, ‘minimal requirements’ and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working party. Crit Rev Oncol Hematol 2016; 98: 189-99. 10.1016/j.critrevonc.2015.10.014BelkacemiYBolleSBourdeautFCollinPCornuPDelatreJYGuidelines, ‘minimal requirements’ and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working partyCrit Rev Oncol Hematol2016981899910.1016/j.critrevonc.2015.10.014Open DOISearch in Google Scholar
Mason WP, Maestro RD, Eisenstat D, Forsyth P, Fulton D, Laperriere N, et al. Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 2007; 14: 110-7. doi: http://dx.doi.org/10.3747/co.2007.1191759398310.3747/co.2007.119MasonWPMaestroRDEisenstatDForsythPFultonDLaperriereNCanadian recommendations for the treatment of glioblastoma multiformeCurr Oncol2007141107http://dx.doi.org/10.3747/co.2007.119Search in Google Scholar
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, et al. ESTRO-ACROP guideline ‘target delineation of glioblastomas’. RadiotherOncol 2016; 118: 35-42. 10.1016/j.radonc.2015.12.003NiyaziMBradaMChalmersAJCombsSEErridgeSCFiorentinoAESTRO-ACROP guideline ‘target delineation of glioblastomas’Radiother Oncol2016118354210.1016/j.radonc.2015.12.003Open DOISearch in Google Scholar
Stupp R, Tonn JC, Brada M, Pentheroudakis G. High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): 190-3. 10.1093/annonc/mdq187StuppRTonnJCBradaMPentheroudakisG.High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol2010215190310.1093/annonc/mdq187Open DOISearch in Google Scholar
Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G. High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25: 93-101. 10.1093/annonc/mdu050StuppRBradaMvan den BentMJTonnJCPentheroudakisG.High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol2014259310110.1093/annonc/mdu050Open DOISearch in Google Scholar
Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 2014; 15: e395-403. 10.1016/S1470-2045(14)70011-725079102WellerMvan den BentMHopkinsKTonnJCStuppRFaliniAEANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaLancet Oncol201415e39540310.1016/S1470-2045(14)70011-7Open DOISearch in Google Scholar
National Comprehensive Cancer Network. Central Nervous System Cancers (Version I.2016). [cited 15 May 2017 ]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf.National Comprehensive Cancer NetworkCentral Nervous System Cancers (Version I.2016)[cited 15 May 2017 ] Available athttps://www.nccn.org/professionals/physician_gls/pdf/cns.pdfSearch in Google Scholar
Kazda T, Jancalek R, Pospisil P, Sevela O, Prochazka T, Vrzal M, et al. Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol 2014; 9: 139. 10.1186/1748-717X-9-13924935286KazdaTJancalekRPospisilPSevelaOProchazkaTVrzalMWhy and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapyRadiat Oncol2014913910.1186/1748-717X-9-139407351724935286Open DOISearch in Google Scholar
Conson M, Cella L, Pacelli R, Comerci M, Liuzzi R, Salvatore M, et al. Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms. Radiother Oncol 2014; 112: 326-31. 10.1016/j.radonc.2014.06.00625012642ConsonMCellaLPacelliRComerciMLiuzziRSalvatoreMAutomated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histogramsRadiother Oncol20141123263110.1016/j.radonc.2014.06.00625012642Open DOISearch in Google Scholar
Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, et al. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 2014; 121: 1115-23. 10.3171/2014.7.JNS13244925192475GrabowskiMMRecinosPFNowackiASSchroederJLAngelovLBarnettGHResidual tumor volume versus extent of resection: predictors of survival after surgery for glioblastomaJ Neurosurg201412111152310.3171/2014.7.JNS13244925192475Open DOISearch in Google Scholar
Pessina F, Navarria P, Cozzi L, Tomatis S, Riva M, Ascolese AM, et al. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. J Neurooncol 2016; 131: 1-8. 10.1007/s11060-016-2310-yPessinaFNavarriaPCozziLTomatisSRivaMAscoleseAMRole of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational studyJ Neurooncol20161311810.1007/s11060-016-2310-y27826681Open DOISearch in Google Scholar
Feng Y, Clayton EH, Okamoto RJ, Engelbach J, Bayly P V, Garbow JR. A longitudinal magnetic resonance elastography study of murine brain tumors following radiation therapy. Phys Med Biol 2016; 61: 6121-31. 10.1088/0031-9155/61/16/612127461395FengYClaytonEHOkamotoRJEngelbachJBaylyPVGarbowJR.A longitudinal magnetic resonance elastography study of murine brain tumors following radiation therapyPhys Med Biol20166161213110.1088/0031-9155/61/16/6121594370227461395Open DOISearch in Google Scholar
Molina D, Pérez-Beteta J, Martínez-González A, Sepúlveda JM, Peralta S, Gil-Gil MJ, et al. Geometrical measures obtained from pretreatment post-contrast T1 weighted MRIs predict survival benefits from bevacizumab in glioblastoma patients. PLoS One 2016; 11: e0161484. 10.1371/journal.pone.0161484MolinaDPérez-BetetaJMartínez-GonzálezASepúlvedaJMPeraltaSGil-GilMJGeometrical measures obtained from pretreatment post-contrast T1 weighted MRIs predict survival benefits from bevacizumab in glioblastoma patientsPLoS One201611e016148410.1371/journal.pone.0161484499646327557121Open DOISearch in Google Scholar
Sreenivasan S, Madhugiri V, Sasidharan G, Kumar RR. Measuring glioma volumes: A comparison of linear measurement based formulae with the manual image segmentation technique. J Cancer Res Ther 2016; 12: 161. 10.4103/0973-1482.15399927072231SreenivasanSMadhugiriVSasidharanGKumarRR.Measuring glioma volumes: A comparison of linear measurement based formulae with the manual image segmentation techniqueJ Cancer Res Ther20161216110.4103/0973-1482.15399927072231Open DOISearch in Google Scholar
Moghaddasi L, Bezak E, Harriss-Phillips W. Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods. Br J Radiol 2015; 88: 1-14. 10.1259/bjr.20150155MoghaddasiLBezakEHarriss-PhillipsW.Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methodsBr J Radiol20158811410.1259/bjr.20150155474357326140450Open DOISearch in Google Scholar
Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 2007; 68: 144-50. doi: http://dx.doi.org/10.1016/j.ijrobp.2006.12.0091730693510.1016/j.ijrobp.2006.12.009ChangELAkyurekSAvalosTRebuenoNSpicerCGarciaJEvaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastomaInt J Radiat Oncol Biol Phys20076814450http://dx.doi.org/10.1016/j.ijrobp.2006.12.00917306935Search in Google Scholar
Aydin H, Sillenberg I, von Lieven H. Patterns of failure following CT-based 3-D irradiation for malignant glioma. Strahlenther Onkol 2001; 177: 424-31.1154490510.1007/PL00002424AydinHSillenbergIvon LievenH.Patterns of failure following CT-based 3-D irradiation for malignant gliomaStrahlenther Onkol200117742431Search in Google Scholar
Bagri PK, Kapoor A, Singh D, Singhal MK, Narayan S, Kumar HS. Addition of magnetic resonance imaging to computed tomography-based three-dimensional conformal radiotherapy planning for postoperative treatment of astrocytomas: Changes in tumor volume and isocenter shift. South Asian J cancer 2015; 4: 18-20. 10.4103/2278-330X.14993925839014BagriPKKapoorASinghDSinghalMKNarayanSKumarHS.Addition of magnetic resonance imaging to computed tomography-based three-dimensional conformal radiotherapy planning for postoperative treatment of astrocytomas: Changes in tumor volume and isocenter shiftSouth Asian J cancer20154182010.4103/2278-330X.149939Open DOISearch in Google Scholar
Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994; 30: 146-9. doi: http://dx.doi.org/10.1016/0167-8140(94)90044-210.1016/0167-8140(94)90044-28184112HessCFSchaafJCKortmannRDSchabetMBambergM.Malignant glioma: patterns of failure following individually tailored limited volume irradiationRadiother Oncol1994301469http://dx.doi.org/10.1016/0167-8140(94)90044-2Open DOISearch in Google Scholar
Easaw JC, Mason WP, Perry J, Laperrière N, Eisenstat DD, Del Maestro R, et al. Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Curr Oncol 2011; 18: e126-36.21655151EasawJCMasonWPPerryJLaperrièreNEisenstatDDDel MaestroRCanadian recommendations for the treatment of recurrent or progressive glioblastoma multiformeCurr Oncol201118e1263610.3747/co.v18i3.755Search in Google Scholar
Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG, Concannon JP, et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989; 16: 1405-9. doi: http://dx.doi.org/10.1016/0360-3016(89)90941-310.1016/0360-3016(89)90941-32542195WallnerKEGalicichJHKrolGArbitEMalkinMGConcannonJPPatterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytomaInt J Radiat Oncol Biol Phys19891614059http://dx.doi.org/10.1016/0360-3016(89)90941-3Open DOISearch in Google Scholar
Halperin EC, Bentel G, Heinz ER, Burger PC. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989; 17: 1347-50. doi: http://dx.doi.org/10.1016/0360-3016(89)90548-810.1016/0360-3016(89)90548-82557310HalperinECBentelGHeinzERBurgerPC.Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlationsInt J Radiat Oncol Biol Phys198917134750http://dx.doi.org/10.1016/0360-3016(89)90548-8Open DOISearch in Google Scholar
Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988; 68: 698-704. 10.3171%2Fjns.1988.68.5.06982833587BurgerPCHeinzERShibataTKleihuesP.Topographic anatomy and CT correlations in the untreated glioblastoma multiformeJ Neurosurg19886869870410.3171%2Fjns.1988.68.5.0698Open DOISearch in Google Scholar
Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 2014; 370: 709-22. 10.1056/NEJMoa130834524552318ChinotOLWickWMasonWHenrikssonRSaranFNishikawaRBevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastomaN Engl J Med20143707092210.1056/NEJMoa1308345Open DOISearch in Google Scholar
Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong Y-K, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2014; 15: 1100-8. 10.1016/S1470-2045(14)70379-125163906StuppRHegiMEGorliaTErridgeSCPerryJHongY-KCilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trialLancet Oncol2014151100810.1016/S1470-2045(14)70379-1Open DOISearch in Google Scholar
Ghose A, Lim G, Husain S. Treatment for glioblastoma multiforme: current guidelines and Canadian practice. Curr Oncol 2010; 17: 52-8. 10.3747/co.v17i6.57421151410GhoseALimGHusainS.Treatment for glioblastoma multiforme: current guidelines and Canadian practiceCurr Oncol20101752810.3747/co.v17i6.574299344121151410Open DOISearch in Google Scholar
Lawrence YR, Li XA, el Naqa I, Hahn CA, Lawrence BM, Merchant TE, et al. QUANTEC: Radiation dse - volume effects in the brain. Int J Radiat Oncol 2010; 76: S77-85. 10.1016/j.ijrobp.2009.02.091LawrenceYRLiXAel NaqaIHahnCALawrenceBMMerchantTEQUANTEC: Radiation dse - volume effects in the brainInt J Radiat Oncol201076S778510.1016/j.ijrobp.2009.02.091355425520171513Open DOISearch in Google Scholar
Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl): 36-41. 10.1016/j.ijrobp.2009.08.078MayoCYorkeEMerchantTE.Radiation associated brainstem injuryInt J Radiat Oncol Biol Phys2010763364110.1016/j.ijrobp.2009.08.078Open DOISearch in Google Scholar
Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl): 28-35. 10.1016/j.ijrobp.2009.07.1753MayoCMartelMKMarksLBFlickingerJNamJKirkpatrickJ.Radiation dose-volume effects of optic nerves and chiasmInt J Radiat Oncol Biol Phys2010763283510.1016/j.ijrobp.2009.07.1753Open DOISearch in Google Scholar
Stupp R, Dietrich PY, Kraljevic SO, Pica A, Maillard I, Maeder P, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002; 20: 1375-82. 10.1200/JCO.2002.20.5.137511870182StuppRDietrichPYKraljevicSOPicaAMaillardIMaederPPromising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideJ Clin Oncol20022013758210.1200/JCO.2002.20.5.1375Open DOISearch in Google Scholar
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81. 10.2307/2281868KaplanELMeierP.Nonparametric estimation from incomplete observationsJ Am Stat Assoc1958534578110.2307/2281868Open DOISearch in Google Scholar
Berty HP, Shi H, Lyons-Weiler J. Determining the statistical significance of survivorship prediction models. J Eval Clin Pract 2010; 16: 155-65. 10.1111/j.1365-2753.2009.01199.x20367827BertyHPShiHLyons-WeilerJ.Determining the statistical significance of survivorship prediction modelsJ Eval Clin Pract2010161556510.1111/j.1365-2753.2009.01199.xOpen DOISearch in Google Scholar
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.5910392MantelN.Evaluation of survival data and two new rank order statistics arising in its considerationCancer Chemother Rep19665016370Search in Google Scholar
International Union Against Cancer. TNM classification of malignant tumours. Sobin LH, Gospodarowicz MK, Wittekind C, editors. 7th Edition. Oxford: Wiley-Blackwell; 2011.International Union Against CancerTNM classification of malignant tumours.SobinLHGospodarowiczMKWittekindC7thOxfordWiley-Blackwell2011Search in Google Scholar
Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 2698122981/CE.3. Lancet Oncol 2008; 9: 29-38. doi: http://dx.doi.org/10.1016/S1470-2045(07)70384-410.1016/S1470-2045(07)70384-418082451GorliaTvan den BentMJHegiMEMirimanoffROWellerMCairncrossJGNomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 2698122981/CE.3Lancet Oncol200892938http://dx.doi.org/10.1016/S1470-2045(07)70384-4Open DOISearch in Google Scholar
Khan L, Soliman H, Sahgal A, Perry J, Xu W, Tsao MN. External beam radiation dose escalation for high grade glioma. Cochrane Database Syst Rev 2016; 8: CD011475. 10.1002/14651858.CD011475.pub2KhanLSolimanHSahgalAPerryJXuWTsaoMN.External beam radiation dose escalation for high grade gliomaCochrane Database Syst Rev20168CD01147510.1002/14651858.CD011475.pub227541334Open DOISearch in Google Scholar
Roa W, Kepka L, Kumar N, Sinaika V, Matiello J, Lomidze D, et al. International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 2015; 33: 4145-50. 10.1200/JCO.2015.62.660626392096RoaWKepkaLKumarNSinaikaVMatielloJLomidzeDInternational Atomic Energy Agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiformeJ Clin Oncol20153341455010.1200/JCO.2015.62.660626392096Open DOISearch in Google Scholar
McDonald MW, Shu H-KG, Curran WJ, Crocker IR. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol 2011; 79: 130-6. 10.1016/j.ijrobp.2009.10.048McDonaldMWShuH-KGCurranWJCrockerIR.Pattern of failure after limited margin radiotherapy and temozolomide for glioblastomaInt J Radiat Oncol201179130610.1016/j.ijrobp.2009.10.04820399036Open DOISearch in Google Scholar
Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 2010; 97: 377-81. 10.1016/j.radonc.2010.08.02020855119MinnitiGAmelioDAmichettiMSalvatiMMuniRBozzaoAPatterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomideRadiother Oncol2010973778110.1016/j.radonc.2010.08.02020855119Open DOISearch in Google Scholar
Dobelbower MC, Burnett III OL, Nordal RA, Nabors LB, Markert JM, Hyatt MD, et al. Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. J Med Imaging Radiat Oncol 2011; 55: 77-81. 10.1111/j.1754-9485.2010.02232.x21382192DobelbowerMCBurnett IIIOLNordalRANaborsLBMarkertJMHyattMDPatterns of failure for glioblastoma multiforme following concurrent radiation and temozolomideJ Med Imaging Radiat Oncol201155778110.1111/j.1754-9485.2010.02232.x21382192Open DOISearch in Google Scholar
Gebhardt BJ, Dobelbower MC, Ennis WH, Bag AK, Markert JM, Fiveash JB. Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide. Radiat Oncol 2014; 9: 130. 10.1186/1748-717X-9-13024906388GebhardtBJDobelbowerMCEnnisWHBagAKMarkertJMFiveashJB.Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomideRadiat Oncol2014913010.1186/1748-717X-9-130405593824906388Open DOISearch in Google Scholar
